Skip to main content
. 2024 Jan 3;14(2):1304–1315. doi: 10.1039/d3ra06993a

Anti-cancer activity results.

Compounds Cell viability (%) ±SD Compounds Cell viability (%) ±SD
50 μM 25 μM 10 μM 50 μM 25 μM 10 μM
22 85.37 ± 4.16 87.49 ± 6.74 92.40 ± 5.38 36 41.20 ± 1.26 46.10 ± 3.32 70.37 ± 5.36
23 34.32 ± 5.29 49.03 ± 9.19 65.14 ± 8.53 37 78.74 ± 2.56 80.51 ± 8.96 85.23 ± 3.50
24 98.54 ± 2.89 100.13 ± 8.93 100.25 ± 8.01 38 67.70 ± 10.82 89.59 ± 9.91 92.04 ± 8.31
25 86.22 ± 9.22 93.24 ± 1.96 98.58 ± 2.25 39 97.50 ± 1.88 98.25 ± 0.34 101.28 ± 9.67
26 54.56 ± 5.61 59.98 ± 8.47 76.61 ± 9.76 40 91.74 ± 9.12 92.81 ± 7.09 99.05 ± 7.70
27 74.75 ± 7.02 89.80 ± 8.75 93.24 ± 8.51 41 44.18 ± 4.11 54.28 ± 6.12 66.70 ± 8.21
28 69.46 ± 17.69 99.07 ± 3.51 102.13 ± 8.51 42 75.55 ± 8.45 78.52 ± 6.58 81.32 ± 7.65
29 88.43 ± 7.36 81.48 ± 2.58 89.10 ± 4.09 43 71.36 ± 10.49 95.16 ± 10.62 99.50 ± 10.20
30 42.82 ± 5.04 55.17 ± 7.06 86.58 ± 3.36 44 89.57 ± 6.27 90.13 ± 6.77 98.41 ± 3.62
31 78.81 ± 10.40 88.47 ± 6.73 81.68 ± 8.36 45 86.98 ± 1.10 91.06 ± 6.00 96.84 ± 5.85
32 72.48 ± 6.24 86.20 ± 8.63 92.51 ± 9.39 46 83.54 ± 7.27 75.49 ± 4.44 80.63 ± 4.70
33 46.98 ± 4.91 63.28 ± 6.32 66.70 ± 8.23 47 81.53 ± 5.45 89.82 ± 2.22 101.77 ± 9.28
34 73.04 ± 2.62 76.76 ± 2.43 78.46 ± 2.43 48 92.89 ± 9.08 93.31 ± 3.60 96.45 ± 4.91
35 75.33 ± 6.17 78.62 ± 10.05 82.40 ± 9.97 YM155 (20 nM) 23.39 ± 3.13
Menadione (20 μM) 23.76 ± 5.70